ライフサイエンスコーパス: bowel habit

1 haracterised by pain, distension and altered bowel habit.

2 symptoms of bloating and pain together with bowel habit.

3 nstipation-predominant IBS) normalized their bowel habits.

4 zed by abdominal pain, bloating, and erratic bowel habits.

5 abdominal discomfort associated with altered bowel habits.

6 nth history of rectal bleeding and change in bowel habits.

7 at least 12 months were surveyed about their bowel habits.

8 abdominal pain and one-quarter with altered bowel habits.

9 stipation-predominant IBS and IBS with mixed bowel habits.

10 There was no history of vomiting or altered bowel habits.

11 20%), aphthous stomatitis (18%), alternating bowel habit (15%), constipation (13%) and gastroesophage

12 for diagnostic colonoscopies were changes in bowel habits (18%) and gastrointestinal bleeding (17%).

13 [51%] vs 40/155 [26%]; p=0.0001), change in bowel habit (36/87 [41%] vs 28/175 [16%]; p<0.0001), wei

14 cations for the colonoscopy included altered bowel habits (7 patients, 64%), screening for colorectal

15 produced rapid and sustained improvement of bowel habits, abdominal symptoms, global relief, and qua

16 ment of novel therapies aimed at normalizing bowel habit alterations and abdominal discomfort, even t

17 l growth and fermentation, prebiotics affect bowel habit and are mildly laxative.

18 o explain symptoms such as bloating, altered bowel habit and discomfort among individuals with irrita

19 r discomfort in association with a change in bowel habit and no organic gastrointestinal disease.

20 idering PPVs for specific cancers, change in bowel habit and rectal bleeding had the highest PPVs for

21 Their bowel habits and a GIQLI questionnaire was performed to

22 th irritable bowel syndrome with alternating bowel habits) and discrete episodes of visible abdominal

23 ta, as did PPVs of abdominal pain, change in bowel habit, and dyspepsia, in those aged 60 years and o

24 r antibiotic use and differences in diet and bowel habit are needed before definitive conclusions can

25 which are selected according to predominant bowel habit), as well as psychological therapies.

26 ory bowel diseases share symptoms of altered bowel habits associated with abdominal pain or discomfor

27 Changes in bowel habit at 3-month intervals were then assessed usin

28 aracterized by abdominal pain and changes in bowel habits, attributed to diverticula but without macr

29 rrent abdominal pain associated with altered bowel habits, but the majority of patients also report n

30 efinition of an alternator (IBS-A), in which bowel habit changes over time.

31 tions has emerged, which can explain altered bowel habits, chronic abdominal pain, and psychiatric co

32 oints included change from baseline in daily bowel habits, daily abdominal symptoms, and weekly globa

33 Patients completed a bowel habit diary and questionnaires on bowel functions

34 I criteria to prospectively assess change in bowel habit for more than 1 year to understand IBS-A.

35 rinary tract symptoms, haematuria, change in bowel habit, hoarseness, fatigue, abdominal pain, lower

36 diarrhea predominance (IBS-D) IBS with mixed bowel habits (IBS-M) share similarities in the microbial

37 ncontinence, and/or (3) normal or disordered bowel habits (ie, fecal retention or diarrhea), and/or (

38 Estimated PPVs were greatest for change in bowel habit in men (4.64% cancer and 2.82% IBD) and for

39 characterized by abdominal pain and altered bowel habits in the absence of obvious anatomic or physi

40 characterized by abdominal pain and altered bowel habits in the absence of specific organic patholog

41 stipation-predominant IBS and IBS with mixed bowel habits in the experimental diet group met the prim

42 doses of linaclotide significantly improved bowel habits, including frequency of spontaneous bowel m

43 "incontinence" and 25% understood the term "bowel habits." More patients recognized word roots than

44 bloating/distension (n = 100,856), change in bowel habit (n = 106,715), rectal bleeding (n = 235,094)

45 storage issues, metabolic syndrome, abnormal bowel habits, obesity, Parkinson's disease, global polyu

46 ors has experienced persistent alteration of bowel habits or malabsorption; only 1 minor wound compli

47 oms or signs (ie, rectal bleeding, change in bowel habit, or anemia) in the 24 months before cancer d

48 ollow-up because of rectal bleeding, altered bowel habits, or cancer (controls).

49 h IBS-C or FC had similar baseline symptoms, bowel habits, oro-cecal and colonic transit, and fasting

50 l syndrome (IBS) is characterized by altered bowel habits, persistent pain and discomfort, and typica

51 For change in bowel habit, persons with lower income, within the healt

52 valence, 40% [95% CI, 35%-45%]), and altered bowel habits (pooled prevalence, 27% [95% CI, 22%-33%]).

53 patients will subsequently have a change in bowel habit, ranging from increased bowel frequency to f

54 All patients with IBS, irrespective of bowel habit, reported significantly greater bloating tha

55 effect of gallbladder FGF19 concentration on bowel habit, stool consistency, lipid levels, BMI or smo

56 ally and this appears to be reflected in the bowel habit subtype.

57 al status (pain catastrophizing, predominant bowel habits, symptom duration, abuse, diagnosable psych

58 characterized by abdominal pain and altered bowel habit that affects ~11% of the global population.

59 siolocal condition characterized by abnormal bowel habits that are frequently accompanied by abdomina

60 l pain) to 63 years (dysphagia and change in bowel habit); the ratio of women/men ranged from 50%:50%

61 d similar rates of abdominal pain, change in bowel habits, use of pain medications, and recent sympto

62 or symptoms of CRC (abdominal pain, altered bowel habits, weight loss, anemia).

63 Her bowel habits were regular, and there was no history of d

64 There was also no correlation of bowel habits with PPARalpha suggesting the observed rise